Verrica Pharmaceuticals Inc. (VRCA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 88.52M |
| Enterprise Value | 60.01M |
| P/E Ratio | -3.62 |
| PEG Ratio | -0.02 |
| Price/Sales Ratio | 1.62 |
| Price/Book Ratio | 3.74 |
| Enterprise/Revenue | 1.1 |
| Enterprise/EBITDA | -3.6 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.48 |
| Operating Margin | -0.36 |
| Return On Assets | -0.46 |
| Return On Equity | -11.36 |
| Revenue | 35.58M |
| Revenue/Share | 3.49 |
| Gross Profit | 32.14M |
| EBITDA | -9.36M |
| Net Income | -17.89M |
| Diluted EPS | -1.68 |
| Total Cash | 20.6M |
| Total Cash/Share | 1.93 |
| Total Debt | 1.44M |
| Total Debt/Equity | 0.09 |
| Current Ratio | 2.02 |
| Book Value Per Share | 1.51 |
| 52-Week Change | -3.92 |
| 52-Week High | 9.82 |
| 52-Week Low | 3.28 |
| Moving Average 50 Days | 6.3 |
| Moving Average 200 Days | 5.91 |
| Average Volume | 73,796 |
| Shares Outstanding | 10.65M |
| % Held by Institutions | 44.85 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | July 25, 2025 |